Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Evi27 encodes a novel membrane protein with homology to the IL17 receptor

Oncogene volume 19, pages 2098–2109 (2000)Cite this article

Abstract

Evi27 is a common site of retroviral integration in BXH2 murine myeloid leukemias. Here we show that integration at Evi27 occurs in a CpG island ∼6 kb upstream from a novel gene (designated Evi27) with homology to the IL17 receptor (Il17r) and that proviral integrations result in increased expression of the Evi27 protein on the cell surface. The human EVI27 homolog was also cloned and mapped to chromosome 3p21. Multiple Evi27 isoforms were detected at the RNA and protein level in both human and mouse, indicating that Evi27 expression is complex. Some of the isoforms are shown to likely represent secreted soluble forms of the protein produced by intron incorporation or by proteolytic cleavage. In the mouse, highest Evi27 expression occurs in liver and testes with lower expression in kidney and lung. In humans, EVI27 is expressed at high levels in the kidney, with moderate levels in the liver, brain, and testes. Within hematopoietic cells, Evi27 expression is restricted. Northern and Western analysis showed that Evi27 is expressed in selected T-cell, B-cell and myeloid cell lines. These results suggest that Evi27 expression is tightly regulated during hematopoietic differentiation. Collectively, these studies identify a new member of the cytokine receptor family whose increased and uncoordinated expression may lead to myeloid leukemia by altering Evi27's normal ability to control the growth and/or differentiation of hematopoietic cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Bagby GC . 1994 The Molecular Basis of Blood Diseases Stamatoyannopoulos G, Nienhuis AW, Majerus PW and Varmus H eds. WB Saunders Press Philadelphia pp 71–106

  • Baumbach WR, Colston EM and Cole MD . 1988 J Virol 62: 3151–3155

  • Bedigian HG, Johnson DA, Jenkins NA, Copeland NG and Evans R . 1984 J Virol 51: 586–594

  • Benton WD and Davis RW . 1977 Science 196: 180–182

  • Blankenstein T, Qin ZH, Li WQ and Diamantstein T . 1990 J Exp Med 171: 965–970

  • Buchburg AM, Bedigian HG, Jenkins NA and Copeland NA . 1990 Mol Cell Biol 10: 4658–4666

  • Chretien S, Moreau-Gachelin F, Apiou F, Courtois G, Mayeux P, Dutrillaux B, Cartron JP, Gisselbrecht S and Lacombe C . 1997 Blood 83: 1813–1821

  • Copeland NG, Jenkins NA, Gilbert DJ, Eppig JT, Maltais LJ, Miller JC, Dietrich WF, Weaver A, Lincoln SE, Steen RG, Stein LD, Nadeau JH and Lander ES . 1993 Science 262: 57–66

  • Copeland NG and Jenkins NA . 1999 Myeloid leukemia disease genes and mouse models In Animal Models of Cancer Predisposition Syndromes Hiai H and Hino O eds Karger Press Basel pp53–63

  • Flubacher MM, Bear SE and Tsichlis PN . 1994 J Virol 68: 7709–7716

  • Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, Pin JJ, Garrone P, Garcia E, Saeland S, Blanchard D, Gaillard C, Das Mahapatra B, Rouvier E, Golstein P, Banchereau J and Lebecque S . 1996 J Exp Med 183: 2593–2603

  • Gilbert DJ, Neumann PE, Taylor BA, Jenkins NA and Copeland NG . 1993 J Virol 67: 2083–2090

  • Gisselbrecht S, Fichelson S, Sola B, Bordereaux D, Hampe A, Andre C, Galibert F and Tambourin P . 1987 Nature 329: 259–261

  • Heaney ML and Golde DW . 1996 Blood 87: 847–857

  • Hino M, Tojo A, Misawa Y, Morii H, Takaku F and Shibuya M . 1991 Mol Cell Biol 11: 5527–5533

  • Jackson TR, Blair LA, Marshall J, Goedert M and Hanley MR . 1988 Nature 335: 437–440

  • Jenkins NA, Copeland NG, Taylor BA, Bedigian HG and Lee BK . 1982 J Virol 42: 379–388

  • Johansson B, Billstrom R, Kristoffersson U, Akerman M, Garwicz S, Ahlgren T, Malm C and Mitelman F . 1997 Leukemia 11: 1207–1213

  • Kennedy J, Rossi DL, Zurawski SM, Vega Jr F, Kastelein RA, Wagner JL, Hannum CH and Zlotnik A . 1996 J Interferon Cytokine Res 16: 611–617

  • Largaespada DA, Shaughnessy Jr JD, Jenkins NA and Copeland NG . 1995 J Virol 69: 5095–5102

  • Li H, Chen J, Huang A, Stinson J, Heldens S, Foster J, Dowd P, Gurney AL and Wood WI . 2000 Proc Natl Acad Sci USA 97: 773–778

  • Li J, Shen H, Himmel K, Dupuy A, Largaespada D, Nakamura T, Shaughnessy J, Jenkins N and Copeland N . 1999 Nat Genet 23: 348–353

  • Liao X, Du Y, Morse III HC, Jenkins NA and Copeland NG . 1997 Oncogene 14: 1023–1029

  • Look AT . 1997 Science 278: 1059–1064

  • Morishita K, Parker DS, Mucenski ML, Jenkins NA, Copeland NG and Ihle JN . 1988 Cell 54: 831–840

  • Nakai K and Kanehisa M . 1992 Genomics 14: 897–911

  • Nakamura T, Largaespada DA, Shaughnessy Jr JD, Jenkins NA and Copeland NG . 1996a Nat Genet 12: 149–153

  • Nakamura T, Largaespada DA, Lee MP, Johnson LA, Ohyashiki K, Toyama K, Chen SJ, Willman CL, Chen I-M, Feinberg AP, Jenkins NA, Copeland NG and Shaughnessy Jr JD . 1996b Nat Genet 12: 154–158

  • Ogawa S, Kurokawa M, Tanaka T, Mitani K, Inazawa J, Hangaishi A, Tanaka K, Matsuo Y, Minowada J, Tsubota T, Yazaki Y and Hirai H . 1996 Oncogene 13: 183–191

  • Penciolelli JF, Wendling F, Robert-Lezenes J, Barque JP, Tambourin P and Gisselbrecht S . 1987 J Virol 61: 579–583

  • Roberts T, Chernova O and Cowell JK . 1998 Hum Mol Genet 7: 1169–1178

  • Rouvier E, Luciani MF, Mattei MG, Denizot F and Golstein P . 1993 J Immunol 150: 5445–5456

  • Sambrook J, Fritsch EF and Maniatis T . 1989 Molecular Cloning A Laboratory Manual Cold Spring Harbor Laboratory Press New York

  • Schwarzenberger P, La Russa V, Miller A, Ye P, Huang W, Zieske A, Nelson S, Bagby GJ, Stoltz D, Mynatt RL, Spriggs M and Kolls JK . 1998 J Immunol 161: 6383–6389

  • Shaughnessy Jr JD, Largaespada DA, Tian E, Fletcher CF, Cho BC, Vyas P, Jenkins NA and Copeland NG . 1999 Oncogene 18: 2069–2084

  • Shi G, Weh HJ, Martensen S, Seeger D and Hossfeld DK . 1996 Cytogenet Cell Genet 74: 295–299

  • Souyri M, Vigon I, Penciolelli JF, Heard JM, Tambourin P and Wendling F . 1990 Cell 63: 1137–1147

  • Sugita T, Totsuka T, Saito M, Yamasaki K, Taga T, Hirano T and Kishimoto T . 1990 J Exp Med 171: 2001–2009

  • Viskochil D, Buchberg AM, Xu G, Cawthorn RM, Stevens J, Wolff RK, Culver M, Carey JC, Copeland NG, Jenkins NA, White R and O'Connell P . 1990 Cell 62: 187–192

  • van den Berg A, Dijkuizen T, Draaijers TG, Hulsbeek MM, Maher ER, van den Berg E, Storkel S and Buys CH . 1997 Genes Chromosomes Cancer 19: 228–232

  • Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, Comeau MR, Cohen JI and Spriggs MK . 1995a Immunity 3: 811–821

  • Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK and Armitage RJ . 1995b J Immunol 155: 5483–5486

  • Yao Z, Spriggs MK, Derry JM, Strockbine L, Park LS, VandenBos T, Zappone JD, Painter SL and Armitage RJ . 1997 Cytokine 9: 794–800

  • Young D, Waitches G, Birchmeier C, Fasano O and Wigler M . 1986 Cell 45: 711–719

  • Ymer S, Tucker WQ, Sanderson CJ, Hapel AJ, Campbell HD and Young IG . 1985 Nature 317: 255–258

Download references

Acknowledgements

We thank Diane E Hasz for technical assistance. This research was sponsored in part by the National Cancer Institute, DHHS, under contract with ABL.

Author information

Authors and Affiliations

  1. Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little Rock, 72205, Arkansas, AR, USA

    Erming Tian, Jeffrey R Sawyer & John D Shaughnessy Jr

  2. Department of Genetics, Cell Biology and Development, University of Minnesota Cancer Center, Minneapolis, 55455, Minnesota, MN, USA

    David A Largaespada

  3. Mouse Cancer Genetics Program, National Cancer Institute-FCRDC, Frederick, 21702, Maryland, MD, USA

    Nancy A Jenkins & Neal G Copeland

Authors
  1. Erming Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeffrey R Sawyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David A Largaespada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nancy A Jenkins
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Neal G Copeland
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. John D Shaughnessy Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tian, E., Sawyer, J., Largaespada, D. et al. Evi27 encodes a novel membrane protein with homology to the IL17 receptor. Oncogene 19, 2098–2109 (2000). https://doi.org/10.1038/sj.onc.1203577

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203577

Keywords

This article is cited by

Search

Advanced search

Quick links